The prevalence of antibody to hepatitis A virus in two populations in Victoria
Lehmann, N.I.; Gust, I.D.
Medical Journal of Australia 2(22): 731-732
1977
ISSN/ISBN: 0025-729X PMID: 205766 Document Number: 118157
Sera collected from a group of 1053 Victorians were tested for antibody to hepatitis A virus by solid phase radioimmunoassay. The group comprised approximately equal numbers of males and females of all ages, 488 of whom lived in Melbourne and 565 in six provincial cities. In both the metropolitan and provincial groups, the prevalence of antibody to hepatitis. A virus was independent of sex and increased steadily with age. Antibody was detected in approximately 20% of children by the age of 10 years, in 40% at 40 years and in excess of 95% above the age of 60 years.
Document emailed within 1 workday
Related Documents
Wu, J.S.; Lu, C.F.; Liu, W.T.; Lin, S.Y. 1991: Prevalence of antibodies to hepatitis C virus (anti-HCV) in different populations in Taiwan Zhonghua Minguo Wei Sheng Wu Ji Mian Yi Xue Za Zhi 24(1): 55-60Lin, H.H.; Hsieh, R.P.; Wang, C.Y.; Chen, P.J.; Chen, D.S. 1991: Prevalence of antibody to hepatitis C virus in pregnant Taiwanese Journal of the Formosan Medical Association 90(5): 476-479
Verdier, M.; Denis, F.; Sangaré, A.; Barin, F.; Gershy-Damet, G.; Rey, J.L.; Soro, B.; Léonard, G.; Mounier, M.; Hugon, J. 1989: Prevalence of antibody to human T cell leukemia virus type 1 (HTLV-1) in populations of Ivory Coast, West Africa Journal of Infectious Diseases 160(3): 363-370
Shams, R.; Khero, R.B.; Ahmed, T.; Hafiz, A. 2001: Prevalence of hepatitis e virus (HEV) antibody in pregnant women of Karachi Journal of Ayub Medical College Abbottabad: Jamc 13(3): 31-35
Minuk, G.Y.; Waggoner, J.G.; Jernigan, R.; Nicolle, L.E.; Postl, B.; Hoofnagle, J.H. 1982: Prevalence of antibody to hepatitis a virus in a Canadian Inuit community Canadian Medical Association Journal 127(9): 850-852
Edelenyi-Pinto, M.; Carvalho, A.P.; Nogueira, C.; Ferreira Júnior, O.; Schechter, M. 1993: Prevalence of antibodies to hepatitis C virus in populations at low and high risk for sexually transmitted diseases in Rio de Janeiro Memorias do Instituto Oswaldo Cruz 88(2): 305-307
Poovorawan, Y.; Theamboonlers, A.; Chongsrisawat, V.; Vimolkej, T.; Nantasook, J. 1997: High prevalence of antibody against hepatitis A virus in an institution for the mentally handicapped Asian Pacific Journal of Allergy and Immunology 15(2): 89-92
Ling, C.M.; Overby, L.R. 1972: Prevalence of hepatitis B virus antigen as revealed by direct radioimmune assay with 125 I-antibody Journal of Immunology 109(4): 834-841
Amitrano, L.; Ascione, A.; Canestrini, C.; D'Agostino, S.; Iaccarino, L.; Vacca, C.; Gigliotti, T. 1990: Prevalence of antibody to hepatitis C virus (anti-HCV) in chronic liver diseases (CLD) in southern Italy Italian Journal of Gastroenterology 22(1): 16-18
Liu, J.; Fan, P.; Xue, X.; Sun, G.; Liu, C.; Tian, S.; Li, J.; Li, N.; Sun, D.; Zhu, Q.; Wang, Z. 2015: Prevalence of hepatitis C virus antibody among newly reported HIV infection cases in Henan, 2012-2014 Zhonghua Liu Xing Bing Xue Za Zhi 36(11): 1269-1273
Sungkanuparph, S.; Vibhagool, A.; Manosuthi, W.; Kiertiburanakul, S.; Atamasirikul, K.; Aumkhyan, A.; Thakkinstian, A. 2004: Prevalence of hepatitis B virus and hepatitis C virus co-infection with human immunodeficiency virus in Thai patients: a tertiary-care-based study Journal of the Medical Association of Thailand 87(11): 1349-1354
Adoga, M.P.; Banwat, E.B.; Forbi, J.C.; Nimzing, L.; Pam, C.R.; Gyar, S.D.; Agabi, Y.A.; Agwale, S.M. 2009: Human immunonodeficiency virus, hepatitis B virus and hepatitis C virus: sero-prevalence, co-infection and risk factors among prison inmates in Nasarawa State, Nigeria Journal of Infection in Developing Countries 3(7): 539-547
Sutcliffe, S.; Taha, T.E.; Kumwenda, N.I.; Taylor, E.; Liomba, G.N. 2002: HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus, and hepatitis B virus infections among male workers at a sugar estate in Malawi Journal of Acquired Immune Deficiency Syndromes 31(1): 90-97
Kazi, A.M.; Shah, S.A.; Jenkins, C.A.; Shepherd, B.E.; Vermund, S.H. 2010: Risk factors and prevalence of tuberculosis, human immunodeficiency virus, syphilis, hepatitis B virus, and hepatitis C virus among prisoners in Pakistan International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 14(Suppl 3): E60-E66
Calderón, G.M.; González-Velázquez, F.; González-Bonilla, C.R.; Novelo-Garza, B.ár.; Terrazas, J.J.; Martínez-Rodríguez, M.L.; Cortés-Márquez, S.R.; Blanco-Flores, J.P.; Rodríguez-Rodríguez, A.; Del Campo, M.A.; Cortés-Gómez, R.; Mejía-Bocanegra, M.G. 2009: Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico Transfusion 49(10): 2200-2207
Vetencourt, R.; de Armas, J.; Vetencourt, M. 1990: Prevalence of the antibody of hepatitis C virus in HBsAg negative patients with chronic liver diseases: children, prostitutes, and homosexuals G.E.N 44(4): 349-352
Son, H.-C.; Yoon, M.-S.; Kim, Y.-J.; Kim, I.-H.; Kim, Y.-S. 2002: Type-specific antibody for hepatitis C virus detected by use of NS-4 peptide and hepatitis C virus genome in Korea Rinsho Byori. Japanese Journal of Clinical Pathology 50(5): 533-540
Rosenblum, L.; Darrow, W.; Witte, J.; Cohen, J.; French, J.; Gill, P.S.; Potterat, J.; Sikes, K.; Reich, R.; Hadler, S. 1992: Sexual practices in the transmission of hepatitis B virus and prevalence of hepatitis delta virus infection in female prostitutes in the United States JAMA 267(18): 2477-2481
Stark, K.; Meyer, C.G.; Tacke, M.; Schwarz, A.; Braun, C.; Huzly, D.; Engel, A.M.; May, J.; Bienzle, U. 1997: Hepatitis G virus RNA and hepatitis G virus antibodies in renal transplant recipients: prevalence and risk factors Transplantation 64(4): 608-612
Iroezindu, M.O.; Daniyam, C.A.; Agbaji, O.O.; Isa, E.S.; Okeke, E.N.; Imade, G.E. 2013: Prevalence of hepatitis B e antigen among human immunodeficiency virus and hepatitis B virus co-infected patients in Jos, Nigeria Journal of Infection in Developing Countries 7(12): 951-959